glp-1 med Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Compounded GLP-1s: Why doctors worry

Unlock Your Health Potential

Dysesthesia The TRIUMPH-4 trial data revealed a notable safety signal: dysesthesia (abnormal sensations like tingling, burning, or numbness) was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose of retatrutide

That means roughly half of patients who accept an initial denial would have been approved had they appealed

This is the mismatch theory: a mismatch between the environment of our evolutionary ancestry that designed our brains to seek foods that were at once rare and nutritious (sweets and fats) and the modern environment in which such foods are in such overabundance that we eat far beyond the saturation point

The net result is unpredictable blood sugar patterns that make diabetes management or weight loss goals harder to track